Estradiolundecylate

CAS: 3571-53-7

Ref. 3D-FE152406

Produktinformation

• Name: Estradiolundecylate
• Synonyme: (17Beta)-3-Hydroxyestra-1,3,5(10)-Trien-17-Yl Undecanoate, Ai3-52642, Delestrec, Depogin, Estra-1,3,5(10)-triene-3,17-diol (17beta)-, 17-undecanoate, Estra-1,3,5(10)-triene-3,17-diol (17β)-, 17-undecanoate, Estradiol 17-undecanoate, Estradiol 17-undecylate, Estradiol undecylate [INN], Estradiol undecylate [USAN:INN], Estradioli undecylas, Estradioli undecylas [INN-Latin], Estradiolo undecilato, Estradiolo undecilato [DCIT], Oestradiol undecylate, Oestradiol-Retard Theramex, Oestradioli undecylas, Primogyn Depot, Sq 9993, Undecilato de estradiol, Undecilato de estradiol [INN-Spanish], Undecylate d'estradiol, Undecylate d'estradiol [INN-French], Unii-H3N3A8Mfjc

Beschreibung

Estradiolundecylate is a pharmaceutical dosage form of estradiol. It is used for the treatment of estrogen deficiency in women and men. Estradiolundecylate has been shown to have a beneficial effect on the lipid profile, which may be due to its ability to increase levels of HDL cholesterol. This drug also has a protective effect against fatty acid-induced testicular hypertrophy in animals. Estradiolundecylate can act as an experimental model for human breast cancer and is used clinically for this purpose.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 440.66 g/mol
• Formel: C₂₉H₄₄O₃
• Reinheit: Min. 95%